Institute of Bioengineering and Nanotechnology (IBN)

IBN was founded in order to promote the advancement of biomedical sciences

The Institute of Bioengineering and Nanotechology (IBN) was established in March 2003 and has 130 employees. IBN is strategically located at The Nanos, within Biopolis, a world-class biomedical sciences R&D hub in Asia.

Jackie Yi-Ru Ying, Prof., Executive Director
Noreena AbuBakar, Director
Nidyah Sani, Head of Corporate Communications

Kenneth A. Smith, Chariman
Galen D. Stucky, Co-Chairman
Viola Vogel
Klavs F. Jensen
Myron Spector

31 Biopolis Way
The Nanos, #04-01
Singapore 138669
Phone: +65-6824-7000
Fax: +65-6478-9080

The institute focuses primarily on the delivery of drugs, tissue engineering, artificial organs and implants, medical devices and biological and biomedical imaging.

The Tissue Engineering section of IBN is investigating custom-designed biomaterials, devices and processes to support liver cell functions and expansion in three-dimensional cultures, engineering of microliver tissues, fibrous scaffolds for tissue engineering, gene transfer systems for versatile genetic modification of stem cells, genetic engineering of human hepatocyte cell lines, growth factor gene delivery and nerve regeneration, influence of extracellular microenvironments on liver cell dynamics and functions, cell tissue engineering.

The Artificial Organs and Implants section is investigating bioactive dental restorative and implant materials, biopolymeric membrane for tympanic membrane repair, collagen-based bone implants for load-bearing applications, computational modeling of the human middle ear, development of middle ear ossicular prosthesis, three-dimensional bone remodelling of nanobiomaterials.